|
1
|
Greenlee RT, Murray T, Bolden S and Wingo
PA: Cancer statistics, 2000. CA Cancer J Clin. 50:7–33. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wakelee HA, Chang ET, Gomez SL, Keegan TH,
Feskanich D, Clarke CA, Holmberg L, Yong LC, Kolonel LN, Gould MK,
et al: Lung cancer incidence in never smokers. J Clin Oncol.
25:472–478. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Huber MA, Kraut N and Beug H: Molecular
requirements for epithelial-mesenchymal transition during tumor
progression. Curr Opin Cell Biol. 17:548–558. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: at the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thompson EW, Newgreen DF and Tarin D:
Carcinoma invasion and metastasis: a role for
epithelial-mesenchymal transition? Cancer Res. 65:5991–5995;
discussion 5995. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Iwatsuki M, Mimori K, Yokobori T, Ishi H,
Beppu T, Nakamori S, Baba H and Mori M: Epithelial-mesenchymal
transition in cancer development and its clinical significance.
Cancer Sci. 101:293–299. 2010. View Article : Google Scholar
|
|
7
|
Bierie B and Moses HL: TGF-beta and
cancer. Cytokine Growth Factor Rev. 17:29–40. 2006. View Article : Google Scholar
|
|
8
|
Feng Y, Li L, Zhang X, Zhang Y, Liang Y,
Lv J, Fan Z, Guo J, Hong T, Ji B, et al: HPIP is overexpressed in
gastric cancer and promotes gastric cancer cell proliferation,
migration and invasion. Cancer Sci. 106:1313–1322. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
van Vuurden DG, Aronica E, Hulleman E,
Wedekind LE, Biesmans D, Malekzadeh A, Bugiani M, Geerts D, Noske
DP, Vandertop WP, et al: Pre-B-cell leukemia homeobox interacting
protein 1 is overexpressed in astrocytoma and promotes tumor cell
growth and migration. Neuro Oncol. 16:946–959. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim AN, Jeon WK, Lim KH, Lee HY, Kim WJ
and Kim BC: Fyn mediates transforming growth factor-beta1-induced
down-regulation of E-cadherin in human A549 lung cancer cells.
Biochem Biophys Res Commun. 407:181–184. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu X, Jiang C, Wang S, Tai Y, Wang T, Kang
L, Fan Z, Li S, Li L, Fu J, et al: HPIP is upregulated in liver
cancer and promotes hepatoma cell proliferation via activation of
G2/M transition. IUBMB Life. 65:873–882. 2013.PubMed/NCBI
|
|
12
|
Bugide S, David D, Nair A, Kannan N,
Samanthapudi VS, Prabhakar J and Manavathi B: Hematopoietic
PBX-interacting protein (HPIP) is over expressed in breast
infiltrative ductal carcinoma and regulates cell adhesion and
migration through modulation of focal adhesion dynamics. Oncogene.
34:4601–4612. 2015. View Article : Google Scholar
|
|
13
|
Feng Y, Xu X, Zhang Y, Ding J, Wang Y,
Zhang X, Wu Z, Kang L, Liang Y, Zhou L, et al: HPIP is upregulated
in colorectal cancer and regulates colorectal cancer cell
proliferation, apoptosis and invasion. Sci Rep. 5:9429–9439. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang SC, Chai DS, Chen CB, Wang ZY and
Wang L: HPIP promotes thyroid cancer cell growth, migration and EMT
through activating PI3K/AKT signaling pathway. Biomed Pharmacother.
75:33–39. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kong FM, Washington MK, Jirtle RL and
Anscher MS: Plasma transforming growth factor-beta 1 reflects
disease status in patients with lung cancer after radiotherapy: a
possible tumor marker. Lung Cancer. 16:47–59. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Akhurst RJ and Derynck R: TGF-beta
signaling in cancer - a double-edged sword. Trends Cell Biol.
11:S44–S51. 2001.PubMed/NCBI
|
|
17
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Moustakas A and Heldin CH: Signaling
networks guiding epithelial-mesenchymal transitions during
embryogenesis and cancer progression. Cancer Sci. 98:1512–1520.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sato M, Shames DS and Hasegawa Y: Emerging
evidence of epithelial-to-mesenchymal transition in lung
carcinogenesis. Respirology. 17:1048–1059. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nakata S, Sugio K, Uramoto H, Oyama T,
Hanagiri T, Morita M and Yasumoto K: The methylation status and
protein expression of CDH1, p16(INK4A), and fragile histidine triad
in nonsmall cell lung carcinoma: epigenetic silencing, clinical
features, and prognostic significance. Cancer. 106:2190–2199. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zavadil J and Böttinger EP: TGF-beta and
epithelial-to-mesenchymal transitions. Oncogene. 24:5764–5774.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Heldin CH, Miyazono K and ten Dijke P:
TGF-beta signalling from cell membrane to nucleus through SMAD
proteins. Nature. 390:465–471. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dumont N and Arteaga CL: Transforming
growth factor-beta and breast cancer: tumor promoting effects of
transforming growth factor-beta. Breast Cancer Res. 2:125–132.
2000. View Article : Google Scholar
|
|
24
|
Risolino M, Mandia N, Iavarone F, Dardaei
L, Longobardi E, Fernandez S, Talotta F, Bianchi F, Pisati F,
Spaggiari L, et al: Transcription factor PREP1 induces EMT and
metastasis by controlling the TGF-β-SMAD3 pathway in non-small cell
lung adenocarcinoma. Proc Natl Acad Sci USA. 111:E3775–E3784. 2014.
View Article : Google Scholar
|
|
25
|
Yamazaki K, Masugi Y, Effendi K, Tsujikawa
H, Hiraoka N, Kitago M, Shinoda M, Itano O, Tanabe M, Kitagawa Y,
et al: Upregulated SMAD3 promotes epithelial-mesenchymal transition
and predicts poor prognosis in pancreatic ductal adenocarcinoma.
Lab Invest. 94:683–691. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Oft M, Akhurst RJ and Balmain A:
Metastasis is driven by sequential elevation of H-ras and Smad2
levels. Nat Cell Biol. 4:487–494. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lv ZD, Kong B, Li J-G, Qu HL, Wang XG, Cao
WH, Liu XY, Wang Y, Yang ZC, Xu HM, et al: Transforming growth
factor-β 1 enhances the invasiveness of breast cancer cells by
inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Oncol Rep. 29:219–225. 2013.
|
|
28
|
Kasai H, Allen JT, Mason RM, Kamimura T
and Zhang Z: TGF-beta1 induces human alveolar epithelial to
mesenchymal cell transition (EMT). Respir Res. 6:56–70. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Willis BC and Borok Z: TGF-beta-induced
EMT: mechanisms and implications for fibrotic lung disease. Am J
Physiol Lung Cell Mol Physiol. 293:L525–L534. 2007. View Article : Google Scholar : PubMed/NCBI
|
